Anti-TB drug resistance levels and patterns among Mycobacterium tuberculosis isolated from newly diagnosed cases of pulmonary tuberculosis in Dar es Salaam, Tanzania

APMIS

Volumn 117, Issue 4, 2009, Pages 263-267

  Matee, Mecky ^a   Mfinanga, Sayoki ^b   Holm Hansen, Carol ^c  

^a MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^b Muhimbili Medical Research Centre   (Tanzania)

^c NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

Anti TB drug resistance; Dar es Salaam; Tanzania

Indexed keywords

ETHAMBUTOL; FUSIDIC ACID; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; LUNG TUBERCULOSIS; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; SPUTUM ANALYSIS; TANZANIA;

ANTITUBERCULAR AGENTS; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; TANZANIA; TUBERCULOSIS;

EID: 63449098907     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2008.02429.x     Document Type: Article

References (17)

1. WHO. Global Tuberculosis Control: Surveillance, Planning, Financing. WHO Report 2006. WHO/HTM/TB/2005.349. Geneva : World Health Organization, 2006.
2. United Republic of Tanzania Ministry of Health: National Tuberculosis and Leprosy Programme. Annual Report, Dar es Salaam, 2003.
3. Mookherji S WDESWHBA. Motivating and Enabling Improved Tuberculosis Case Detection in Tanzania. Summary Report, 2004.
4. Kamerbeek J, Schouls L, Kolk A, van Agterveld M, van Soolingen D, Kuijper S, et al. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol 1997 35 : 907 14.
5. Maher D, Chaulet P, Spinaci S, Harries AD. Treatment of Tuberculosis: Guidelines for National Programmes. 2nd ed. WHO/TB/97.220. Geneva : World Health Organization, 1997.
6. Mookherji S. WDESWHBA: Motivating and Enabling Improved Tuberculosis Case Detection in Tanzania. Summary Report, 2004.
7. United Republic of Tanzania, Ministry of Health and Social Welfare: National Tuberculosis and Leprosy Programme, Temeke district Tuberculosis and Leprosy. Annual Report 2000. Dar Es Salaam, 2001.
8. United Republic of Tanzania, Ministry of Health. National Tuberculosis and Leprosy Programme. Annual Report 2000. Dar Es Salaam, 2001.
9. Range N, Ipuge YA, O'Brien RJ, Egwaga SM, Mfinanga SG, Chonde TM, et al. Trend in HIV prevelance among tuberculosis patients in Tanzania, 1991-1998. IntJ Tuber Lung Dis 2001 5 : 405 12.
10. United Republic of Tanzania. Ministry of Health. End of Phase 1 Report 1998. Adult Morbidity and Mortality Project (AMMP). Dar es Salaam, Tanzania : Ministry of Health, 1998.
11. Kent PT, Kubica GP. Public Health Mycobacteriology: A Guide for the Level III Laboratory. Atlanta, GA : U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 1985.
12. Yang ZH, Mtoni I, Chonde M, Mwasekaga M, Fuursted K, Askgård DS, et al. DNA fingerprinting and phenotyping of Mycobacterium tuberculosis isolates from human immunodeficiency virus (HIV)-seropositive and HIV-seronegative patients in Tanzania. J Clin Microbiol 1995 33 : 1064 9.
13. Kibiki GS, Mulder B, Dolmans WM, de Beer JL, Boeree M, Sam N, et al. M. tuberculosis genotypic diversity and drug susceptibility pattern in HIV-infected and non-HIV-infected patients in northern Tanzania. BMC Microbiol 2007 7 : 51.
14. Wandwalo E, Makundi E, Hasler T, Odd Morkve O. Acceptability of community and health facility-based directly observed treatment of tuberculosis in Tanzanian urban setting. Health Policy 2005 78 : 284 94.
15. WHO. Anti-Tuberculosis Drug Resistance in the World: The WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Geneva : World Health Organization, 1997 (document WHO/TB/97.229).
16. WHO. Anti-Tuberculosis Drug Resistance in the World: the WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Geneva : World Health Organization, 2000 (document WHO/CDS/TB/2000.278).
17. Eldholm V, Matee M, Mfinanga SGM, Heun M, Dahle UR. A first insight into the genetic diversity of Mycobacterium tuberculosis in Dar es Salaam, Tanzania, assessed by spoligotyping. BMC Microbiol 2006 6 : 76.